BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18423453)

  • 1. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.
    Darney P; Patel A; Rosen K; Shapiro LS; Kaunitz AM
    Fertil Steril; 2009 May; 91(5):1646-53. PubMed ID: 18423453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
    Yao XY; Du MK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):419-22. PubMed ID: 12921554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.
    Graesslin O; Korver T
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():4-12. PubMed ID: 18330813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding related to etonogestrel subdermal implant in a US population.
    Casey PM; Long ME; Marnach ML; Bury JE
    Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
    Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
    Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
    Croxatto HB
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial.
    Mommers E; Blum GF; Gent TG; Peters KP; Sørdal TS; Marintcheva-Petrova M
    Am J Obstet Gynecol; 2012 Nov; 207(5):388.e1-6. PubMed ID: 22939402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Implanon insertion and removal.
    Levine JP; Sinofsky FE; Christ MF;
    Contraception; 2008 Nov; 78(5):409-17. PubMed ID: 18929739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etonogestrel implant (Implanon) for contraception.
    Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy with Implanon: a report on three cases].
    Boucoiran I; Trastour C; Faraj L; Delotte J; Bongain A
    Gynecol Obstet Fertil; 2011 Feb; 39(2):e52-4. PubMed ID: 21288755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population.
    Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C
    Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implanon status report: not on U.S. market yet.
    Contracept Technol Update; 1999 Aug; 20(8):87-9. PubMed ID: 12295255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion and removal of Implanon: practical considerations.
    Mascarenhas L
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The progestagen-containing implant (Implanon); who is responsible for what?].
    van den Bosch WJ
    Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1758-60. PubMed ID: 15495937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.